Dyslipidemia after kidney transplantation and correlation with cyclosporine level: a glimpse into the future
- PMID: 24693513
- PMCID: PMC3955280
- DOI: 10.5812/numonthly.14179
Dyslipidemia after kidney transplantation and correlation with cyclosporine level: a glimpse into the future
Keywords: Cyclosporine; Kidney Transplantation; Lipids.
Comment on
- Nephrourol Mon. 5(3):831.
Similar articles
-
Dyslipidemia after kidney transplantation and correlation with cyclosporine level.Nephrourol Mon. 2013 Jul 1;5(3):831-4. doi: 10.5812/numonthly.11890. Epub 2013 Jun 14. Nephrourol Mon. 2013. PMID: 24282795 Free PMC article.
-
Dyslipidemia can reduce the immunosuppressive effects of cyclosporine.Transpl Immunol. 2008 Feb;18(4):349-51. doi: 10.1016/j.trim.2007.10.002. Epub 2007 Oct 25. Transpl Immunol. 2008. PMID: 18158122
-
Dyslipidemia in human kidney transplant recipients receiving cyclosporine and tacrolimus is associated with different expression of CD36 on peripheral blood monocytes.Transplant Proc. 2011 Jun;43(5):1612-5. doi: 10.1016/j.transproceed.2011.03.015. Transplant Proc. 2011. PMID: 21693242
-
Rapamycin in combination with cyclosporine or tacrolimus in liver, pancreas, and kidney transplantation.Transplant Proc. 2003 May;35(3 Suppl):201S-208S. doi: 10.1016/s0041-1345(03)00231-8. Transplant Proc. 2003. PMID: 12742497 Review.
-
Statins' dosage in patients with renal failure and cyclosporine drug-drug interactions in transplant recipient patients.Int J Cardiol. 2005 May 11;101(1):9-17. doi: 10.1016/j.ijcard.2004.04.005. Int J Cardiol. 2005. PMID: 15860377 Review.
References
-
- Kasiske B, Cosio FG, Beto J, Bolton K, Chavers BM, Grimm R, Jr, et al. Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Am J Transplant. 2004;4 Suppl 7:13–53. doi: 10.1111/j.1600-6135.2004.0355.x. - DOI - PubMed
-
- Ahmed MH, Khalil AA. Ezetimibe as a potential treatment for dyslipidemia associated with chronic renal failure and renal transplant. Saudi J Kidney Dis Transpl. 2010;21(6):1021–9. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources